Mauro talks with Vlasta Hakes, the Corporate Affairs Director with Grifols Biomat. She explains their health-care company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines. Grifols has recently opened a new center on the UMass Medical Center to specifically collect plasma from those people who have recovered from COVID-19 to be used in the production of a medicine that could potentially treat COVID-19.
Posted March 2nd 2021 8:48pm.